Uterine artery embolization for symptomatic uterine fibroids

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 12, 2014, Pages

  Gupta, Janesh K ^a   Sinha, Anju ^b   Lumsden, M A ^c   Hickey, Martha ^d  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL HYSTERECTOMY; BLOOD TRANSFUSION; COMPARATIVE STUDY; FERTILITY; FOLLOW UP; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LIVE BIRTH; MYOMECTOMY; OPERATION DURATION; PATIENT SAFETY; PATIENT SATISFACTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; TREATMENT INDICATION; UTERINE ARTERY EMBOLIZATION; UTERUS MYOMA; ARTIFICIAL EMBOLISM; FEMALE; HYSTERECTOMY; LEIOMYOMA; META ANALYSIS; PROCEDURES; UTERINE NEOPLASMS; VASCULARIZATION;

EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; HYSTERECTOMY; LEIOMYOMA; LENGTH OF STAY; PATIENT SATISFACTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; UTERINE ARTERY EMBOLIZATION; UTERINE NEOPLASMS;

EID: 84925223257     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD005073.pub4     Document Type: Review

References (37)

1. Hehenkamp WJK, Volkers NA, Birnie E, Reekers JA, Ankum WM. Pain and return to daily activities after uterine artery embolization and hysterectomy in the treatment of symptomatic uterine fibroids: Results from the randomized EMMY trial. Cardiovascular Interventional Radiology 2006;29:179-87.
2. Hehenkamp WJK, Volkers NA, Birnie E, Reekers JA, Ankum WM. Symptomatic uterine fibroids: Treatment with uterine artery embolization or hysterectomy - results from the randomized clinical embolization versus hysterectomy (EMMY) trial. Radiology 2008;246(3):823-32.
3. Hehenkamp WJK, Volkers NA, Broekmans FJM, de Jong FH, Themmen APN, Birnie E, et al. Loss of ovarian reserve after uterine artery embolization: a randomised comparison with hysterectomy. Human Reproduction 2007;22:1996-2005.
4. Hehenkamp WJK, Volkers NA, Donderwinkel PFJ, de Blok S, Birnie E, Ankum WA, et al. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): Peri- and postprocedural results from a randomized controlled trial. American Journal of Obstetrics and Gynecology 2005;193:1618-29.
5. Volkers NA, Hehenkamp WJ, Smit P, Ankum WM, Reekers JA, Birnie E. Economic evaluation of uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: results from the randomized EMMY trial. Journal of Vascular Interventional Radiology 2008;19:1007-17.
6. Volkers NA, Hehenkamp WJK, Birnie E, Ankum WM, Reekers JA. Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years' outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology 2007;196:519e.1-11.
7. van der Kooij SM, Hehenkamp WJK, Volkers NA, Birnie E, Ankum WM, Reekers JA. Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5-year outcome from the randomized EMMY trial. American Journal of Obstetrics and Gynecology 2010;203:105.e1-13.
8. Manyonda IT, Bratby M, Horst JS, Banu N, Gorti M, Belli A-M. Uterine artery embolization versus myomectomy: Impact on quality of life - results of the FUME (Fibroids of the Uterus: Myomectomy versus Embolization) trial. Cardiovascular and Interventional Radiology 2012;35(3):530-6.
9. Jun F, Yamin L, Xinli X, Zhe L, Min Z, Bo Z, Wenli G. Uterine artery embolization versus surgery for symptomatic uterine fibroids: a randomized controlled trial and a meta-analysis of the literature. Archives of Gynecology and Obstetrics 2012;285:1407-13.
10. Mara M, Fucikovaa Z, Maskova J, Kuzela J, Haakova L. Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2006;126:226-33.
11. Mara M, Maskova J, Fucikova Z, Kuzel D, Belsan T, Sosna O. Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovascular and Interventional Radiology 2008;31:73-85.
12. Pinto I, Chimeno P, Romo L, Haya J, De la Cal M, Bajo J. Uterine fibroids: Uterine artery embolization versus abdominal hysterectomy for treatment. A prospective randomized and controlled trial. Radiology 2003;226(2):425-31.
13. Edwards RD, Moss JG, Lumsden MA, Wu O, Murray LS, Twaddle S, et al. Uterine artery embolization versus surgery for symptomatic uterine fibroids. New England Journal of Medicine 2007;356:360-70.
14. Moss JG, Cooper KG, Khaund A, Murray LS, Murray GD, Wu O, et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5 year results. British Journal of Obstetrics and Gynaecology 2011;118(8):936-44.
15. Rashid S, Khaund A, Murray LS, Moss JG, Cooper K, Lyons D, et al. The effects of uterine artery embolisation and surgical treatment on ovarian function in women with uterine fibroids. British Journal of Obstetrics and Gynaecology 2010;117:985-9.
16. Ruuskanen A, Hippelainen M, Sipola P, Manninen H. Uterine artery embolisation versus hysterectomy for leiomyomas: primary and 2-year follow-up results of a randomised prospective clinical trial. European Radiology 2010;20(10):2524-32.
17. Hald K, Kløw NE, Qvigstad E, Istre O. Laparoscopic occlusion compared with embolization of uterine vessels: a randomized controlled trial. Obstetrics and Gynecology 2007;109:20-7.
18. McKinnon W. Treating Fibroids with either Embolisation or Myomectomy to Measure the Effect on quality of life among women wishing to avoid hysterectomy: The FEMME study. ISRCTN registry accessed 26 November 2014.
19. Broder MS, Kanouse DE, Mittman BS, Bernstein SJ. The appropriateness of recommendations for hysterectomy in Southern California. Obstetrics and Gynaecology 2000;95(2):199-205.
20. Cardozo ER. Clark AD. Banks NK. Henne MB. Stegmann BJ. Segars JH. The estimated annual cost of uterine leiomyomata in the United States. American Journal of Obstetrics & Gynecology 2012;206(3):211.e1-9.
21. Coleman P. Review body for interventional procedures, Sheffield: Commissioned by the National Institute for Clinical Excellence. National Institute for Clinical Excellence 2004.
22. Garry R, Fountain J, Mason S, Hawe J, Napp V, Abbott J, et al. The eVALuate study: two parallel randomised trials, one comparing laparoscopic with abdominal hysterectomy, the other comparing laparoscopic with vaginal hysterectomy. BMJ 2004;328(7432):129.
23. Gehlbach DL, Sousa RC, Carpenter SE, Rock JA. Abdominal myomectomy in the treatment of infertility. International Journal of Gynaecology and Obstetrics 1993;40(1):45-50.
24. Goodwin S, Vendantham S, McLucas B, Forno A, Perella R. Preliminary experience with uterine fibroid embolization for uterine fibroids. Journal of Vascular and Interventional Radiology 1997;8:517-26.
25. Greenwood C, Glickman M, Schwartz P, Morse SS, Denny DF. Obstetric and non malignant gynecologic bleeding: Treatment with angiographic embolization radiology. Radiology 1987;164(1):155-9.
26. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
27. Dutton S, Hirst A, McPherson K, Nicholson T, Maresh M. A UK multicentre retrospective cohort study comparing hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids (HOPEFUL study): main results on medium-term safety and efficacy. British Journal of Obstetrics and Gynaecology 2007;114:1340-51.
28. Khaund A, Lumsden MA. Impact of fibroids on reproductive function. Best Practice & Research Clinical Obstetrics and Gynaecology 2008;22(4):749-56.
29. Lepine LA, Hillis SD, Marchbanks PA, Koonin LM, Morrow B, Kicke BA, et al. Hysterectomy surveillance. United States 1980-1983. Morbidity and Mortality Weekly Reports 1997;46 (SS-4):1-16.
30. National Centre for Health Statistics. Ambulatory and Inpatient Procedures in the United States, 1996. Hyattsville, Maryland: Public Health Service 1998; DHSS Publication No (PHS) 99-1710.
31. National Institute for Health and Care Excellence. Heavy menstrual bleeding. http://www.nice.org.uk/guidance/cg44 (accessed 22 December 2014).
32. Okolo S. Incidence, aetiology and epidemiology of uterine fibroids. Best Practice & Research Clinical Obstetrics and Gynaecology 2008;22(4):571-88.
33. Donnez J, Tatarchuk TF, Bouchard P, et al. Ulipristal acetate versus placebo for fibroid treatment before surgery. New England Journal of Medicine 2012;366(5):409-20.
34. Donnez J, Tomaszewski J, Vázquez F. Ulipristal acetate versus leuprolide acetate for uterine fibroids. New England Journal of Medicine 2012;366(5):421-32.
35. Rahn DD, Abed H, Sung VW, Matteson KA, Rogers RG, Morrill MY, et al. Systematic review highlights difficulty interpreting diverse clinical outcomes in abnormal uterine bleeding trials. J Clin Epidemiol 2011;64(3):293-300.
36. Ravina JH, Bouret JM, Ciraru-Vigneron N, Repiqurt D, Herbreteau D, Aymard A, et al. Recourse to particular arterial embolization in the treatment of some uterine leiomyoma. Bulletin de Academie Nationale de Medecine 1997;181(2):233-43.
37. Spies JB, Warren EH, Mathias SD, Walsh SM, Roth AR, Pentecost MJ. Uterine fibroid embolization: measurement of health-related quality of life before and after therapy. Journal of Vascular and Interventional Radiology 1999;10(10):1293-303.